Background: The impact of diet on breast cancer prognosis is poorly understood. Therefore, we conducted a literature search summarizing the current evidence on the effect of diet on breast cancer recurrence and mortality. Methods: The PubMed database was searched for original studies, reviews, and meta-analyses published between 2010 and 2017. Studies related to diet, dietary patterns, special diets or specific dietary factors, and breast cancer recurrence or mortality were included. Results: Adherence to high diet quality indices (relative risk (RR) 0.74, 95% confidence interval (CI) 0.60-0.90) and a prudent/healthy dietary pattern (RR 0.76, 95% CI 0.60-0.95) may have a beneficial effect on breast cancer prognosis, whereas a Western/unhealthy diet is associated with poorer overall mortality (RR 1.44, 95% CI 1.17-1.77). For low-fat diets, the findings are inconsistent. A positive effect of the Mediterranean Diet was found for all-cause mortality, but no beneficial effect from other diets such as low-carbohydrate, ketogenic or vegetarian/vegan diets was observed. Alcohol consumption was associated with an increased risk for breast cancer recurrence. No general recommendation for soy exists, but occasional intake seems to be acceptable, whereas the use of other supplements is not justified. Conclusion: Adherence to high-quality diets and a prudent/healthy dietary pattern seem to be beneficial for breast cancer prognosis. No clear evidence for a benefit from special diets, soy products, or other supplements was found.

Keywords:
Breast cancer, Diet, Dietary pattern, Recurrence, Mortality
1.
Robert Koch-Institut: Bericht zum Krebsgeschehen in Deutschland 2016. 2016. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebsgeschehen/Krebsgeschehen_download.pdf?__blob=publicationFile.
2.
Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC: Dietary factors and the survival of women with breast carcinoma. Cancer 1999;86:826-835.
3.
Fink BN, Gaudet MM, Britton JA, Abrahamson PE, Teitelbaum SL, Jacobson J, Bell P, Thomas JA, Kabat GC, Neugut AI, Gammon MD: Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res Treat 2006;98:199-208.
4.
McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H: Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer 2006;55:132-140.
5.
Saxe GA, Rock CL, Wicha MS, Schottenfeld D: Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 1999;53:241-253.
6.
Patterson RE, Cadmus LA, Emond JA, Pierce JP: Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 2010;66:5-15.
7.
Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Navarro Rosenblatt D, Thune I, Vieira R, Norat T: Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014;25:1901-1914.
8.
Kwan ML, Chen WY, Kroenke CH, Weltzien EK, Beasley JM, Nechuta SJ, Poole EM, Lu W, Holmes MD, Quesenberry CP, Pierce JP, Shu XO, Caan BJ: Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat 2012;132:729-739.
9.
Chen X, Lu W, Zheng W, Gu K, Chen Z, Zheng Y, Shu XO: Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 2010;122:823-833.
10.
Ibrahim EM, Al-Homaidh A: Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 2011;28:753-765.
11.
Chlebowski RT: Nutrition and physical activity influence on breast cancer incidence and outcome. Breast 2013;22(suppl 2):S30-37.
12.
Dieli-Conwright CM, Lee K, Kiwata JL: Reducing the risk of breast cancer recurrence: an evaluation of the effects and mechanisms of diet and exercise. Curr Breast Cancer Rep 2016;8:139-150.
13.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA: Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-2486.
14.
Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC: Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol 2016;34:1315-1322.
15.
Pierce JP, Patterson RE, Senger CM, Flatt SW, Caan BJ, Natarajan L, Nechuta SJ, Poole EM, Shu X-O, Chen WY: Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst 2014;106:djt359.
16.
Kwan ML, Bernard PS, Kroenke CH, Factor RE, Habel LA, Weltzien EK, Castillo A, Gunderson EP, Maxfield KS, Stijleman IJ, Langholz BM, Quesenberry CP, Kushi LH, Sweeney C, Caan BJ: Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst 2015;107:pii: djv087.
17.
Hauner D, Janni W, Rack B, Hauner H: The effect of overweight and nutrition on prognosis in breast cancer. Dtsch Arztebl Int 2011;108:795-801.
18.
World Cancer Research Fund International: Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Breast Cancer Survivors. 2014. www.wcrf.org/sites/default/files/Breast-Cancer-Survivors-2014-Report.pdf.
19.
Chlebowski RT, Blackburn GL, Thomson CA, et al: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98:1767-1776.
20.
Pierce JP, Natarajan L, Caan BJ, et al: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007;298:289-298.
21.
Kroenke CH, Fung TT, Hu FB, Holmes MD: Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol 2005;23:9295-9303.
22.
Kim EHJ, Willett WC, Fung T, Rosner B, Holmes MD: Diet quality indices and postmenopausal breast cancer survival. Nutr Cancer 2011;63:381-388.
23.
Kwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan BJ: Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol 2009;27:919-926.
24.
Izano MA, Fung TT, Chiuve SS, Hu FB, Holmes MD: Are diet quality scores after breast cancer diagnosis associated with improved breast cancer survival? Nutr Cancer 2013;65:820-826.
25.
Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J: Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer 2013;108:188-192.
26.
Schwedhelm C, Boeing H, Hoffmann G, Aleksandrova K, Schwingshackl L: Effect of diet on mortality and cancer recurrence among cancer survivors: a systematic review and meta-analysis of cohort studies. Nutr Rev 2016;74:737-748.
27.
Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G: Adherence to Mediterranean Diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients 2017;9:pii: E1063.
28.
Toledo E, Salas-Salvadó J, Donat-Vargas C, et al: Mediterranean diet and invasive breast cancer risk among women at high cardiovascular Risk in the PREDIMED trial: a randomized clinical trial. JAMA Intern Med 2015;175:1752-1760.
29.
Villarini A, Pasanisi P, Traina A, et al: Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori 2012;98:1-18.
30.
Rock CL, Natarajan L, Pu M, Thomson CA, Flatt SW, Caan BJ, Gold EB, Al-Delaimy WK, Newman VA, Hajek RA, Stefanick ML, Pierce JP: Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Cancer Epidemiol Biomarkers Prev 2009;18:486-494.
31.
Dinu M, Abbate R, Gensini GF, Casini A, Sofi F: Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr 2017;57:3640-3649.
32.
Harashima E, Nakagawa Y, Urata D, Tsuji K, Shirataka M, Matsumura Y: Time-lag estimate between dietary intake and breast cancer mortality in Japan. Asia Pac J Clin Nutr 2007;16:193-198.
33.
Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML: Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev 2011;20:890-899.
34.
Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, Caan BJ: Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 2010;28:4410-4416.
35.
Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta SJ, Poole EM, Holmes MD, Patterson RE, Shu XO, Pierce JP, Caan BJ: Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 2013;22:32-41.
36.
Nechuta S, Chen WY, Cai H, Poole EM, Kwan ML, Flatt SW, Patterson RE, Pierce JP, Caan BJ, Ou Shu X: A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer 2016;138:2088-2097.
37.
Ali AMG, Schmidt MK, Bolla MK, et al: Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases. Cancer Epidemiol Biomarkers Prev 2014;23:934-945.
38.
World Cancer Research Fund International/American Institute for Cancer Research: Continuous Update Project Report: Diet, Nutrition, Physical Activity and Breast Cancer. 2017. www.wcrf.org/sites/default/files/CUP_BREAST_REPORT_2017_WEB.pdf.
39.
World Cancer Research Fund International: Our Cancer Prevention Recommendations, 2018. www.wcrf.org/int/research-we-fund/our-cancer-prevention-recommendations (accessed January 30, 2018).
40.
Deutsche Gesellschaft für Ernährung e.V.: Alkohol: Richtwert für Alkohol. www.dge.de/wissenschaft/referenzwerte/alkohol/ (accessed January 30, 2018).
41.
Hauner D: Soja and Mammakarzinom: Wirkung und Sicherheit zur Primärprävention und bei bereits Erkrankten. Gynäkologische Praxis 2017;42:683-691.
42.
Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnell SL: Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 2017;317:1234-1243.
43.
Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, Pizot C, Boniol M: Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 2017;5:986-1004.
44.
Hamer J, Warner E: Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health. CMAJ 2017;189:E268-E274.
45.
Velicer CM, Ulrich CM: Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665-673.
46.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M: How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012;11:187-203.
47.
Nahleh Z, Tabbara IA: Complementary and alternative medicine in breast cancer patients. PAX 2003;1:136.
48.
Huebner J, Marienfeld S, Abbenhardt C, Ulrich CM, Muenstedt K, Micke O, Muecke R, Loeser C: Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res 2014;34:39-48.
49.
Greenlee H, Gammon MD, Abrahamson PE, Gaudet MM, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS: Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer 2009;115:3271-3282.
50.
Arends J, Bertz H, Bischoff S, Fietkau R, Herrmann H, Holm E, Horneber M, Hütterer E, Körber J, Schmid I: S3-Leitline der Deutschen Gesellschaft für Ernährungsmedizin e.V. (DGEM) in Kooperation mit der Deutschen Gesellschaft für Hämatologie und Onkologie e.V. (DGHO), der Arbeitsgemeinschaft ‘Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin' der Deutschen Krebsgesellschaft (ASORS) und der Österreichischen Arbeitsgemeinschaft für klinische Ernährung (AKE). Aktuel Ernahrungsmed 2015;40:e1-e74.
51.
Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008;100:773-783.
52.
Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH: Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113:5927-5937.
53.
Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier J-P, Têtu B, Harel F, Abdous B, Vigneault E, Vass S, Del Vecchio P, Roy J: Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005;23:5805-5813.
54.
Tanvetyanon T, Bepler G: Beta‐carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers. Cancer 2008;113:150-157.
55.
Brasky TM, White E, Chen C-L: Long-term, supplemental, one-carbon metabolism-related vitamin B use in relation to lung cancer risk in the Vitamins and Lifestyle (VITAL) cohort. J Clin Oncol 2017;35:3440-3448.
56.
Wien TN, Pike E, Wisløff T, Staff A, Smeland S, Klemp M: Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open 2012;2: e000653.
57.
Rutkowski M, Grzegorczyk K: Adverse effects of antioxidative vitamins. Int J Occup Med Environ Health 2012;25:105-121.
58.
World Cancer Research Fund International: Cancer survivors. www.wcrf.org/int/research-we-fund/cancer-prevention-recommendations/cancer-survivors (accessed January 25, 2018).
59.
Hauner H, Hauner D: The impact of nutrition on the development and prognosis of breast cancer. Breast Care (Basel) 2010;5:377-381.
60.
Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R: Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 2005;23:774-782.
61.
Vance V, Mourtzakis M, McCargar L, Hanning R: Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 2011;12:282-294.
62.
Rack B, Andergassen U, Neugebauer J, Salmen J, Hepp P, Sommer H, Lichtenegger W, Friese K, Beckmann MW, Hauner D, Hauner H, Janni W: The German SUCCESS C study - the first european lifestyle study on breast cancer. Breast Care (Basel) 2010;5:395-400.
63.
Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB: Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009;119:1093-1100.
64.
Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB: Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation 2008;118:230-237.
65.
Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD: Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 2011;13:R64.
© 2018 S. Karger GmbH, Freiburg
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.